💨 Abstract
The U.S. approved Moderna's new COVID-19 vaccine, mNexspike, on May 31, 2025. Designed as a second option, it uses a lower dose and is approved for adults 65+ and high-risk individuals aged 12-64. trials show it matches or exceeds the effectiveness of the prior vaccine, Spikevax. Availability for both vaccines is expected to begin this fall.
Courtesy: WTOP Staff
Suggested
No. 10 overall seed Mississippi beats Murray State 19-8 to stay alive in Oxford Regional -
Asian shares slide as Russia-Ukraine conflict, OPEC+ output plan push oil prices higher -
In Uganda, an affordable alternative to dirt floors is a big boost to human health -
Harvey Weinstein doesn’t plan to testify at sex crimes retrial -
AP PHOTOS: 6 injured in a Colorado attack the FBI is investigating as terrorism -
FBI says suspect in Colorado attack that injured 6 yelled ‘Free Palestine’ and used makeshift flamethrower -
NCAA Division I Baseball Regionals Glance -
Denny Hamlin races at Nashville hoping birth of his third child holds off -
Wright State hangs on late to win 5-4, knocks No. 1 national seed Vanderbilt out of NCAA regionals -
AP PHOTOS: A look at May’s most compelling images from around the world -